Linked Life Data

19839993

Source:http://linkedlifedata.com/resource/pubmed/id/19839993

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2009-10-20
pubmed:abstractText
Asenapine is approved for bipolar disorder and schizophrenia. This was a 3-week, randomized, double-blind, placebo-controlled trial of asenapine for treating acute bipolar mania.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1399-5618
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
673-86
pubmed:dateRevised
2010-6-24
pubmed:meshHeading
pubmed-meshheading:19839993-Adult, pubmed-meshheading:19839993-Aged, pubmed-meshheading:19839993-Antipsychotic Agents, pubmed-meshheading:19839993-Benzodiazepines, pubmed-meshheading:19839993-Bipolar Disorder, pubmed-meshheading:19839993-Body Weight, pubmed-meshheading:19839993-Dose-Response Relationship, Drug, pubmed-meshheading:19839993-Double-Blind Method, pubmed-meshheading:19839993-Electroencephalography, pubmed-meshheading:19839993-Female, pubmed-meshheading:19839993-Heterocyclic Compounds with 4 or More Rings, pubmed-meshheading:19839993-Humans, pubmed-meshheading:19839993-Male, pubmed-meshheading:19839993-Middle Aged, pubmed-meshheading:19839993-Models, Statistical, pubmed-meshheading:19839993-Patient Compliance, pubmed-meshheading:19839993-Psychiatric Status Rating Scales, pubmed-meshheading:19839993-Single-Blind Method, pubmed-meshheading:19839993-Time Factors, pubmed-meshheading:19839993-Treatment Outcome, pubmed-meshheading:19839993-Young Adult
pubmed:year
2009
pubmed:articleTitle
A 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed states.
pubmed:affiliation
Department of Psychiatry and Pharmacology, University of Toronto, Toronto, ON, Canada. roger.mcintyre@uhn.on.ca
pubmed:publicationType
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study, Clinical Trial, Phase I